Right now, there are two FDA approved drugs to treat Alzheimer's itself. Find out why Remternetug may soon get approval as a third, even better treatment.
Kisunla, the newest Alzheimer's drug, is rapidly gaining acceptance around the world. Learn what it does and how to get it.
How do the new drugs Leqembi and Kisunla fight Alzheimer's? Surprisingly, increases in amyloid-beta protein levels can explain the slowing of Alzheimer's at least as well as the reduction in amyloid plaques.
Ely Lilly unveils new $1,000,000,000 facility for drugs including Kisunla for Alzheimer's. New investment will enhance global medicine production, benefiting millions of patients worldwide
Diabetes and prediabetes are dementia risk factors. They affect 1 in 7 adults! Learn about new research to lower that risk with lifestyle and drugs.
There are no approved treatments for DLB, though it is the second most common type of dementia. Do drugs like donepezil hold the key?
In the USA, the same person may be twice as likely to be told they have dementia, depending on where they are diagnosed. Learn more to get a more accurate test and better treatment.
Older adults with a genetic predisposition to Alzheimer’s disease may benefit from fish oil supplements.
While the initial headlines might seem discouraging, there’s always more to the story. 🌟
University of Oxford research revealed groundbreaking findings that could reshape dementia prevention. Ozempic (AKA Semaglutide/Wegovy), a type-2 diabetes and weight-loss drug, seems to significantly reduce the risk of dementia.
The newest Alzheimer's drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer's. How do they compare to each other?
VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer's plaque 84%.
